314 related articles for article (PubMed ID: 28395969)
1. Ultrasmall polymeric nanocarriers for drug delivery to podocytes in kidney glomerulus.
Bruni R; Possenti P; Bordignon C; Li M; Ordanini S; Messa P; Rastaldi MP; Cellesi F
J Control Release; 2017 Jun; 255():94-107. PubMed ID: 28395969
[TBL] [Abstract][Full Text] [Related]
2. Construction and evaluation of novel αvβ3 integrin ligand-conjugated ultrasmall star polymer micelles targeted glomerular podocytes through GFB permeation.
Huang C; Zhao X; Su M; Yin Z
Biomaterials; 2021 Sep; 276():121053. PubMed ID: 34352625
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional podocyte-endothelial cell co-cultures: Assembly, validation, and application to drug testing and intercellular signaling studies.
Li M; Corbelli A; Watanabe S; Armelloni S; Ikehata M; Parazzi V; Pignatari C; Giardino L; Mattinzoli D; Lazzari L; Puliti A; Cellesi F; Zennaro C; Messa P; Rastaldi MP
Eur J Pharm Sci; 2016 Apr; 86():1-12. PubMed ID: 26924225
[TBL] [Abstract][Full Text] [Related]
4. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
5. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.
Li C; Ge Y; Peng A; Gong R
Oncotarget; 2015 Nov; 6(37):39493-506. PubMed ID: 26567873
[TBL] [Abstract][Full Text] [Related]
6. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
7. Targeting signaling pathways in glomerular diseases.
Henique C; Tharaux PL
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):417-27. PubMed ID: 22660552
[TBL] [Abstract][Full Text] [Related]
8. Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular Injury.
Stevens M; Neal CR; Salmon AHJ; Bates DO; Harper SJ; Oltean S
Nephron; 2018; 139(1):51-62. PubMed ID: 29393270
[TBL] [Abstract][Full Text] [Related]
9. Enhanced podocyte differentiation and changing drug toxicity sensitivity through pressure-controlled mechanical filtration stress on a glomerulus-on-a-chip.
Doi K; Kimura H; Kim SH; Kaneda S; Wada T; Tanaka T; Shimizu A; Sano T; Chikamori M; Shinohara M; Matsunaga YT; Nangaku M; Fujii T
Lab Chip; 2023 Jan; 23(3):437-450. PubMed ID: 36546862
[TBL] [Abstract][Full Text] [Related]
10. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
Aluri R; Jayakannan M
Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
[TBL] [Abstract][Full Text] [Related]
11. Podocyte injury and repair mechanisms.
Cellesi F; Li M; Rastaldi MP
Curr Opin Nephrol Hypertens; 2015 May; 24(3):239-44. PubMed ID: 26066473
[TBL] [Abstract][Full Text] [Related]
12. Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.
Tian X; Ishibe S
Nephrol Dial Transplant; 2016 Oct; 31(10):1577-83. PubMed ID: 26968197
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury.
Zhou Y; Kong X; Zhao P; Yang H; Chen L; Miao J; Zhang X; Yang J; Ding J; Guan Y
Kidney Int; 2011 Jun; 79(12):1302-11. PubMed ID: 21368746
[TBL] [Abstract][Full Text] [Related]
15. Toward the development of podocyte-specific drugs.
Reiser J; Gupta V; Kistler AD
Kidney Int; 2010 Apr; 77(8):662-8. PubMed ID: 20130528
[TBL] [Abstract][Full Text] [Related]
16. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
17. Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers.
Zhang F; Zhang S; Pollack SF; Li R; Gonzalez AM; Fan J; Zou J; Leininger SE; Pavía-Sanders A; Johnson R; Nelson LD; Raymond JE; Elsabahy M; Hughes DM; Lenox MW; Gustafson TP; Wooley KL
J Am Chem Soc; 2015 Feb; 137(5):2056-66. PubMed ID: 25629952
[TBL] [Abstract][Full Text] [Related]
18. Podocyte energy metabolism and glomerular diseases.
Imasawa T; Rossignol R
Int J Biochem Cell Biol; 2013 Sep; 45(9):2109-18. PubMed ID: 23806869
[TBL] [Abstract][Full Text] [Related]
19. Molecular make-up of the glomerular filtration barrier.
Patrakka J; Tryggvason K
Biochem Biophys Res Commun; 2010 May; 396(1):164-9. PubMed ID: 20494132
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
